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The Jeotgalicoccus sp. peroxygenase cytochrome P450OleTJE
(CYP152L1) is a hydrogen peroxide-driven oxidase that cata-
lyzes oxidative decarboxylation of fatty acids, producing termi-
nal alkenes with applications as fine chemicals and biofuels.
Understanding mechanisms that favor decarboxylation over
fatty acid hydroxylation in OleTJE could enable protein engi-
neering to improve catalysis or to introduce decarboxylation
activity into P450s with different substrate preferences. In this
manuscript, we have focused on OleTJE active site residues
Phe79, His85, and Arg245 to interrogate their roles in substrate
binding and catalytic activity. His85 is a potential proton donor
to reactive iron-oxo species during substrate decarboxylation.
The H85Qmutant substitutes a glutamine found in several per-
oxygenases that favor fatty acid hydroxylation. H85Q OleTJE
still favors alkene production, suggesting alternative protona-
tion mechanisms. However, the mutant undergoes only minor
substrate binding-induced heme iron spin state shift toward
high spin by comparison with WT OleTJE, indicating the key
role of His85 in this process. Phe79 interacts with His85, and
Phe79 mutants showed diminished affinity for shorter chain
(C10–C16) fatty acids and weak substrate-induced high spin
conversion. F79AOleTJE is least affected in substrate oxidation,
whereas the F79W/Y mutants exhibit lower stability and cys-
teine thiolate protonation on reduction. Finally, Arg245 is cru-
cial for binding the substrate carboxylate, and R245E/L muta-
tions severely compromise activity and heme content, although
alkeneproducts are formed fromsome substrates, including ste-
aric acid (C18:0). The results identify crucial roles for the active
site amino acid trio in determiningOleTJE catalytic efficiency in
alkene production and in regulating protein stability, heme iron
coordination, and spin state.
The cytochromes P450 (P450s or CYPs) are a superfamily of
heme b-containing mono-oxygenase enzymes widespread in
nature and spanning all three domains of life: archaea, bacteria,
and eukaryota (1). Most P450s catalyze reductive scission of
dioxygen bound to their heme iron, relying on the delivery of
two electrons acquired from pyridine nucleotide cofactors
(NADPH or NADH). In the canonical P450 catalytic cycle, two
electrons are donated at discrete points in the cycle via a redox
partner protein (2). The first electron is delivered to the sub-
strate-bound, cysteine thiolate-coordinated ferric heme iron,
reducing it to the ferrous form, allowing dioxygen to bind. The
second electron reduces this ferric-superoxo complex to the
ferric-peroxo state. As shown in Fig. 1, two successive protona-
tions of iron-oxo species then occur. Protons are typically
relayed from a conserved acid-alcohol amino acid pair
(e.g. Asp251/Thr252 in the camphor hydroxylase P450cam,
CYP101A1) to form first the ferric-hydroperoxo species (com-
pound 0) and then the highly reactive ferryl-oxo, heme radical
cation species compound I (with loss of a watermolecule) (3, 4).
The P450 compound I abstracts a hydrogen from the substrate
to form the ferryl-hydroxo (compound II) form, prior to oxidiz-
ing the substrate to complete the catalytic process (5).
Although most P450s operate in this way, several are also
known to catalyze substrate oxidation using the “peroxide
shunt”mechanism, inwhichH2O2or an organic hydroperoxide
(e.g. meta-chloroperoxybenzoic acid) convert a substrate-
bound resting state of the P450 directly to compound 0 (Fig. 1)
(4, 6). As in the canonical cycle, a further protonation of com-
pound 0 leads to formation of compound I and to oxidative
catalysis. In many P450s, this reaction is inefficient, and oxida-
tive damage to the protein and/or heme occurs alongside any
productive turnover (7). However, certain P450s have evolved
to use the peroxide shunt efficiently for substrate oxidation.
The best characterized P450s are in the CYP152 family of per-
oxygenases. These enzymes may have evolved in ancient pro-
karyotes at a time when the environment was devoid of oxygen,
but relatively rich in hydrogen peroxide and peroxygenated
organic compounds. Although peroxygenase activity is likely to
have evolved in archaea, it has been conserved in P450s from
bacteria and eukaryotes, including humans (8).
Among the best characterized of the CYP152 family peroxy-
genases is the industrially relevant OleTJE (CYP152L1), first
isolated from Jeotgalicoccus sp. ATCC 8456 in 2011 by
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Schirmer and co-workers (9). OleTJE acts primarily as a H2O2-
dependent fatty acid decarboxylase to form terminal alkenes
but also hydroxylates a proportion of these substrates to gener-
ate - and -hydroxylated fatty acids. Lipid substrates with
chain lengthsC12-C20 were shown to be good substrates (9,
10). Later studies showed that the P450cam redox partner sys-
tem (NADH-putidaredoxin reductase and putidaredoxin),
along with a NADH recycling system) could also be used effec-
tivelywithOleTJE to decarboxylate alkanoic acids as short asC4
(11). OleTJE also functions as a typical P450 mono-oxygenase
when fused to the phthalate dioxygenase reductase-like domain
of CYP116B2 (RhFRED) from Rhodococcus sp. NCIMB9784
(12) or by utilizing the flavodoxin/flavodoxin reductase system
of Escherichia coli in vivo (12, 13). OleTJE is also active when
used in conjunction with a light-driven, in situ H2O2-generat-
ing system (14).
Transient formation of P450 compound I in OleTJE was
reported by Makris and co-workers (15) on the addition of
H2O2 to OleTJE in complex with perdeuterated arachidic acid,
and identified by the appearance of a characteristic 370-nm
Soret maximum and an additional absorption band at 690 nm.
These spectral data are similar to those reported by Rittle and
Green (4) in studies with Sulfolobus acidocaldariusCYP119A1.
The transient capture of compound I in the perdeuterated sub-
strate-bound form of OleTJE likely results from a 2H-kinetic
isotope effect on compound I decay. Compound I formation is
considered to initiate fatty acid decarboxylation by abstracting
a substrate hydrogen atom (15).
As an alkene-producing enzyme, OleTJE has attracted inter-
est for industrial applications, including in the production of
biofuels and petrochemicals (16). In vivo production of alkenes
was reported in E. coli strains transformed with OleTJE (12).
Yan et al. (17) also developed systems in which the tandem
activities of a lipase and OleTJE were used to produce 1-alkenes
from low cost triacylglycerol feedstocks.
Other prominent members of the CYP152 peroxygenase
family include Bacillus subtilis P450 BS (CYP152A1, 41%
sequence identity to OleTJE) and Sphingomonas paucimobilis
P450 SP (CYP152B1, 37% sequence identity to OleTJE) (10).
Both enzymes are primarily fatty acid hydroxylases, with P450
FIGURE 1. The OleTJE catalytic cycle.OleTJE catalyzes the oxidative decarboxylation of fatty acids (major reaction) and can also hydroxylate fatty acids at the
- and -positions (minor reaction). The canonical P450 catalytic cycle is shown in circular representation, initiating with the binding of fatty acid substrate
(shown as RH, and also as a chemical structure) that converts the LSOleTJE P450 to aHS form. Shown in gray arrows from this point onwards are reduction (2)
and protonation (1) steps that follow the canonical path and require one or more redox partners. The thick black arrow traversing the cycle illustrates the
“peroxide shunt” pathway by which ferric, fatty acid-bound OleTJE can be converted directly to the transient ferric-hydroperoxo (compound 0) form using
H2O2. At this point, the canonical andperoxide shuntpathways convergewith aprotonation step that results indehydrationof a transient intermediate to form
the ferryl-oxo compound I. Compound I deprotonates the substrate, producing a substrate radical and the ferryl-hydroxo compound II. At this stage, the
catalytic pathways for substrate hydroxylation and decarboxylation diverge. Hydroxylated fatty acids are formed by the “radical rebound” mechanism (5), as
shown in the outer loop to the left of themain cycle (gray arrows). However, recent studies have indicated that that fatty acid decarboxylation to form terminal
alkenes likely involves an unusually stable compound II and that reduction of compound II (or another oxidant) by the substrate radical could form a substrate
diradical or carbocation species that decomposes with CO2 release to form the terminal alkene product (15, 39). The P450 heme (illustrated by the iron in the
relevant oxidation state and equatorial/axial bonds) is shaded to approximate the color of the relevant heme intermediate species.
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SP hydroxylating 100% at the C position, and P450 BS ini-
tially reported to hydroxylate at 43% in the C position and
57% in the C position (18). However, studies by Rude et al.
(9) showed that P450 BS produced 1-pentadecene at15% of
total product alongside - and -hydroxylated palmitic acid
products. Crystal structure data show that the active sites of
OleTJE and P450 BS are very similar, with the carboxylate
group of fatty acid substrates being coordinated by a conserved
arginine residue (Arg245 in OleTJE, Arg242 in P450 BS, and
Arg241 in P450 SP) (10, 18). An R242A mutant of P450 BS
abolished fatty acid hydroxylase activity, whereas an R242K
mutation substantially reduced substrate hydroxylation (19).
A key difference in the active sites of OleTJE and P450 BS is
at position 85 (His85 in OleTJE and Gln85 in P450 BS) (10). In
OleTJE, theHis85 imidazole side chain points into the active site
toward the heme iron. This orientation sandwiches the imidaz-
ole side chain between the heme and Phe79. It was postulated
that the difference in the nature of the residue at position 85
may underlie the strong decarboxylase activity of OleTJE. His85
could act as a proton donor to the compound I intermediate,
together with its reduction to compound II using an electron
from the fatty acid substrate carboxylate group.Homolytic scis-
sion of the C-C bond of the fatty acid, concomitant with
abstraction of a hydrogen from C to form compound II, could
then produce the terminal alkene and CO2 products (10). Rude
et al. investigated the role of the residue at position 85 in P450
BS by creating the Q85H mutant. During in vitro turnover
experiments with hexadecanoic acid, the P450 BS Q85H
mutation resulted in decreased -hydroxy-hexadecanoic acid
formation and in increased 1-pentadecene and -hydroxy
hexadecanoic acid formation. Despite this, the ratio of decar-
boxylation to hydroxylation only increased from 0.19 in WT
P450 BS to 0.30 in the P450 BSQ85Hmutant, comparedwith
a ratio of 3.32 in OleTJE (9).
Through its interactions with His85 in OleTJE, Phe79 is also
likely to be important for catalytic activity in OleTJE. A pheny-
lalanine (Phe79) is retained at this position in P450 BS. How-
ever, the exclusive fatty acid -hydroxylase P450 SP has a leu-
cine at the corresponding position (Leu79). In P450 BS, the
F79Lmutation resulted in increased -hydroxylation, with lev-
els of -hydroxylation falling from 58 to 17% of the overall
product (20).
In this study, we explore further the structure and mecha-
nism of OleTJE by mutating the key active site residues His85,
Phe79, and Arg245 and by analyzing their effects on the catalytic
properties of this biotechnologically important alkene-produc-
ing enzyme. The H85Q mutant was characterized to establish
whether His85 is crucial to OleTJE decarboxylase activity and
also because its replacement by Glu85 in P450 BS results
mainly in fatty acid hydroxylation (Fig. 2). The importance of
Phe79 in its interactions with His85 and in regulating active site
structure and catalytic activity were explored by characteriza-
tion of F79A, F79W, and F79Y variants. Finally, the fatty acid
carboxylate coordinating Arg245 was mutated to neutral
(R245L) and charge reversal (R245E) variants to assess influ-
ence on activity and regioselectivity of substrate oxidation.
Mutants were characterized by a combination of kinetic, spec-
troscopic, structural, and analytical methods to provide new
insights into OleTJE structure/function.
Results
Expression and Purification of OleTJE and OleTJE Mutants—
The expression, purification and structural characterization of
the WT OleT P450 were reported by Belcher et al. (10). The
structural data for the substrate-bound and substrate-free
forms of OleTJE were used to design mutations to explore the
fatty acid carboxylate binding site of the P450. The codon-op-
timized OleTJE (CYP152L1) gene was cloned into pET15b, and
site-directed mutagenesis was done to create the H85Q, F79A,
F79W, F79Y, R245E, and R245L mutants. All mutants were
found to express reasonably well in the E. coliC41 (DE3) strain.
Typical OleTJE mutant recovery was 15 mg/liter for H85Q
and F79W, 8 mg/liter for F79Y and R245L, 2 mg/liter for F79A,
and 1.5 mg/liter for the R245E OleTJE mutant, compared with
20 mg/liter for WT OleTJE. The heme precursor -aminole-
vulinic acid (500 M) was added at the point of induction of
OleTJE mutant gene expression with isopropyl 1-thio--D-ga-
lactopyranoside to aid heme incorporation. However, heme
insertion levels were diminished in the R245E and R245L
mutants (25–35% heme incorporation). The simultaneous
addition of hemin (4g/ml) at the point of induction increased
heme incorporation by5–10% in these mutants.
All OleTJE mutants were purified in the same way, using
nickel-iminodiacetic acid (Ni-IDA)2 chromatography. Samples
for enzymatic/spectroscopic assayswere frozen after ensuring a
high level of purity by SDS-PAGE. Samples destined for crys-
tallographywere treatedwithTEVprotease to cleave theN-ter-
minal His tag and then passed through a Ni-IDA column to
separate the untagged form from column-retained tagged
OleTJE. Gel filtration chromatography was used to further
purify untagged OleTJE proteins, and samples were then used
directly in crystallographic trials. Fig. 3 shows an SDS-PAGEgel
containing samples of purified WT and mutant OleTJE pro-
teins. The F79W, F79Y, R245E, and R245L OleTJE mutants
proved less stable than the WT and the H85Q and F79A
mutants in that they were prone to aggregation and precipita-
tion on refrigeration or during crystallization trials. However,
theH85QandF79AOleTJE P450swere successfully crystallized
for structural analysis (see “Structural Properties of OleTJE
Mutant Enzymes” below).
UV-visible Absorbance Properties of OleTJE Mutants—When
purified fromE. coli, theWT, ferricOleTJE exhibits amixed low
spin (LS)/high spin (HS) heme iron state that can be converted
essentially completely to a LS form by the addition of H2O2.
This likely indicates that fatty acids from E. coli are bound and
retained by the enzyme during the purification process. The
WT OleTJE was extensively dialyzed to remove bound fatty
acids. However, this mixed spin character was absent in all
OleTJE mutants generated, suggesting that the mutations may
compromise affinity for mid-chain to long chain fatty acids
through structural perturbation of the P450 active site.
2 The abbreviations used are: Ni-IDA, nickel-iminodiacetic acid; LS, low spin;
HS, high spin; BBSRC, Biotechnology and Biological Sciences Research
Council.
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InWTOleTJE, the ferric heme Soret peak is at 418.5 nm,with
the and bands at567 and 535 nm, respectively. TheH85Q
mutant has a similar spectrum with a Soret peak at 418.5 nm,
whereas the F79A/W/Y mutants have Soret maxima at 419/
419/419.5 nm. In the R245Emutant, there is a substantial spec-
tral change, with the Soret peak at 423 nm and a major
Q-band feature at538 nm. This phenomenon is not observed
in the R245L OleTJE (Soret maximum at 417.5 nm, with /
bands at 566/535 nm), indicating that the R245E mutation
alters the heme environment in the distal pocket (Fig. 4A).
FIGURE 2.Alignment of OleTJE with other bacterial peroxygenase P450s.OleTJE (CYP152L1) is aligned with the peroxygenases P450 KR from K. rhizophila,
CYP-MP (P450MP) from M. populi (30), a peroxygenase from Bacillus clausii (P450BC) (9), B. subtilis P450 BS (CYP152A1) (27), S. paucimobilis P450 SP
(CYP152B1) (28), and C. acetobutylicum P450 CLA (CYP152A2) (33). The OleTJE active site residues Phe
79, His85 and Arg245 are in bold, red font. Non-conserved
residues at these positions are shown in bold, blue font. Arg245 and the adjacent Pro246 are conserved in all the peroxygenases. Other completely conserved
residues are indicated in bold, underlined black font.
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A likely model is that Glu245 coordinates the R245E mutant
heme iron, as was demonstrated previously in the A264E
mutant of Bacillus megaterium P450 BM3 (CYP102A1) (21).
Spectral differences are observed between the dithionite-re-
ducedWTandmutant forms ofOleTJE. ForWTOleTJE, reduc-
tion is associated with a decreased Soret peak intensity and a
shift in absorption maximum to 415 nm, with merging of the 
and  bands into a broad feature peaking at 540 nm (10).
Similar spectral shifts occur on the reduction ofOleTJEmutants
H85Q and F79A (Soret shifts to 416.5 and 418 nm). However,
for F79W and F79Y OleTJE, the Soret band is red-shifted to
422 nm with peak intensity less diminished than in the WT
and the H85Q/F79A variants. The red shift suggests that cys-
teine thiolate protonation occurs in the F79Y/W variants (22).
In reduced R245E OleTJE, the Soret peak shifts to 417.5 nm,
with a Q-band peak at 547.5 nm, whereas in reduced R245L
the Soret is at 420 nm with / bands at 559/536 nm.
Further comparative studies of the heme environments in
WT and mutant OleTJE proteins were done using the FeII-CO
complexes of these P450s. The WT OleTJE formed predomi-
nantly the P450 state with a Soret band at 449 nm and a smaller
P420 feature at 423 nm. These bands originate from OleTJE
FeII-CO complexes in which the proximal ligand is either a
cysteine thiolate (P450) or a cysteine thiol (P420) (23, 24). The
P450:P420 ratio differs considerably between WT OleTJE and
the various mutants. Under the conditions used, the highest
P450:P420 ratio occurs for theWTOleTJE with a P450 compo-
nent of75%. H85Q has a similar proportion of P450 (70%)
but P450 content decreases in the F79Ymutant (45%, similar
to the F79A/W mutants), and the R245E mutant forms almost
completely the P420 form (10% P450) (Fig. 4B). These data
show that active site mutations influence the OleTJE variant
heme environments, including perturbation of the proximal
ligand protonation state in the ferrous and/or FeII-CO forms.
Although the heme iron of R245E OleTJE is likely coordinated
byGlu245 carboxylate in the ferric state, CO can clearly displace
this distal ligand in the ferrous state of the enzyme. The ferrous
R245L/Emutant Soret spectral peaks are similarly positioned at
416.5/417 nm, suggesting displacement of a Glu245 distal ligand
in the ferrous state for the R245E mutant. The R245L mutant
also forms amuch higher proportion of the P450 FeII-CO com-
plex at35% (not shown).
Interactions of WT and Mutant OleTJE Proteins with Fatty
Acid Substrates—To examine the influence of lipid substrates
on OleTJE ferric heme iron spin state equilibrium and to deter-
mine Kd values for substrate binding, fatty acids of different
chain lengths were titrated withWT andmutant OleTJE P450s.
For WT OleTJE, binding of arachidic acid (C20:0) gives an
extensive shift toward HS ferric heme iron, with decreased
Soret band intensity at418 nm and increased HS band inten-
sity at 389 nm. Development of HS character is further con-
firmed by the appearance of a thiolate to HS ferric heme iron
charge transfer band at650 nm. For WTOleTJE, the amount
of HS heme formed decreases as the fatty acid chain length
decreases. The Kd values remain low for saturated fatty acids
tested in the chain length range from C20 to C14, but affinity
FIGURE 3. Purification of WT and active site mutants of OleTJE. The gel
image shows the purified forms (from left to right) of WT OleTJE and its active
site mutants H85Q, F79A, F79W, F79Y, R245L and R245E. The outside lanes
showproteinmarkerswith their associatedmolecularmasses (kDa) indicated
(NEB Broad Range Protein Ladder).
FIGURE 4.UV-visible spectroscopy of OleTJE and key active site mutants. A shows typical UV-visible absorption spectra for the ferric, substrate-free forms
ofWT (black), H85Q (red), F79Y (green), and R245E (blue) OleTJE. The spectra are nearly identical at the heme Soret and protein (280 nm) peaks for theWT and
H85Q forms (both at 5 M) and reflect essentially complete heme incorporation into these proteins. However, the heme/protein (Reinheitszahl, Rz) ratio is
much lower in the F79Y and R245EOleTJEmutants, indicating lower heme incorporation in these variants. B shows the Fe
II-CO complexes of the sameproteins
(corrected to 5 M by heme content in all cases), showing that the WT and H85Q mutants form predominantly the cysteine thiolate-coordinated P450 form,
with a proportion of the thiol-coordinated P420 state. There is a considerably greater proportion of the P420 species in the F79Y mutant, whereas the R245E
mutant forms almost completely the P420 form. The P450 species have a Soretmaximumat 448 1 nmand the P420 species a Soretmaximumat 422 1 nm
in all cases.
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decreases considerably for C12 and C10 substrates; e.g. Kd 
1.73 0.08M for palmitic acid (C16:0) compared with 47.1
2.1 M for capric acid (C10:0) (Table 1).
Binding of arachidic acid also induces HS heme formation in
H85Q and F79AOleTJEmutants but with amuch less extensive
HS shift than seen in WT OleTJE. At apparent saturation with
arachidic acid, the Soret band shifts to415 nm for H85Q and
to 414 nm for F79A OleTJE. Arachidic acid spectral binding
data for WT and the H85Q OleTJE mutant are compared in
(Fig. 5). Despite incomplete HS shifts in these mutants, sub-
strate turnover data confirm that both the H85Q and F79A
mutant P450s can oxidize fatty acids in the C10-C20 range (see
“Products Formed by Novel OleTJE Mutants” below). Thus,
productive substrate binding occurs for these fatty acids in both
mutants. These mutations may influence the binding mode of
the fatty acid and its carboxylate group,which in turn affects the
efficiency with which the substrate can displace the distal water
ligand to convert the P450s to a HS state. The reaction of H2O2
with substrate-bound OleTJE generates reactive heme species
(ferryl-oxo and ferryl-hydroxo compounds I and II; Fig. 1) that
oxidize the substrate, and the retention of catalytic activity in
the H85Q/F79A mutants indicates that fatty acid binding
modes remain close to this reactive iron-oxo species such that
hydroxylation (at substrate - and -carbons) and decarboxy-
lation remain feasible.
It should be noted that for P450 BS and P450 SP (where
residue 85 is a glutamine), the HS shift upon substrate binding
is very small (BS) or not observed at all (SP) (25). The H85Q
OleTJE mutant thus mimics the spectral properties of these
other bacterial peroxygenases on binding fatty acid substrates.
For both theH85Q and F79AOleTJEmutants, there is a pattern
of increasing substrate Kd values as the fatty acid chain length
decreases, consistent with the properties of WT OleTJE and
likely reflecting the fewer hydrophobic interactions made by
shorter chain substrates in the active site channel (Table 1).
The F79W and F79YOleTJE proteins showmodest spin state
shifts with most fatty acids tested, suggesting again that the
binding modes of these substrates are perturbed. However, in
the F79Y OleTJE, there is a notable increase in HS content on
saturation with lauric acid (C12:0,25% high spin) and myris-
tic acid (C14:0, 20% high spin) compared with longer chain
fatty acids (10% for arachidic acid, stearic acid (C18:0) and
palmitic acid). This suggests that these shorter chain fatty acids
can adopt binding modes in F79Y OleTJE that are compatible
with more efficient displacement of the distal water molecule
than can occur with longer chain substrates, probably in part
because of their greater solubility. With the exception of the
R245E OleTJE variant, the Kd values for the longest substrates
(C20:0 and C18:0) are similar for the WT and mutant OleTJE
enzymes (Table 1). As fatty acid chain length decreases from
C16:0, there arewider variations in the substrateKd values, with
allmutants apart fromR245E (see below) showingweaker bind-
ing of fatty acids from C16:0 to C10:0 by comparison with the
WT OleTJE.
FIGURE 5. Fatty acid binding titrations with WT and mutant OleTJE proteins. A shows a UV-visible spectral binding titration for WT OleTJE (5.5 M) with
arachidic acid (C20:0). There is extensive conversion of the LS heme iron (at 418.5 nm) toward HS (at 395 nm). HS heme iron development is also evident from
the development of a cysteine thiolate-to-HS ferric heme iron charge transfer species at650 nm. The inset shows the fitting of absorbance change versus
[arachidic acid] using the Hill function, producing an apparent Kd of 4.43 0.19M. B, shows a titration of theOleTJE H85Qmutant (5.6M)with arachidic acid,
in this case producing a much smaller spectral conversion toward HS. The inset shows the fit of induced absorption change (418.5–415 nm) versus [arachidic
acid], fitted as above to give a Kd of 5.27 0.05 M. C shows a titration of the OleTJE R245E mutant (4.7 M) with capric acid (C10:0), with absorption change
(422.5–384 nm) versus [capric acid] data fitted using a hyperbolic function to give a Kd of 1260 160 M.
TABLE 1
Binding affinity of saturated fatty acids for WT andmutant forms of OleTJE
The dissociation constants (Kd values) for the binding of the saturated fatty acids decanoic acid (capric acid, C10:0), dodecanoic acid (lauric acid, C12:0), tetradecanoic acid
(myristic acid, C14:0), hexadecanoic acid (palmitic acid, C16:0), octadecanoic acid (stearic acid, C18:0), and arachidic acid (eicosanoic acid, C20:0) were determined by
UV-visible titration with WT OleTJE and with the H85Q, R245E, and F79A/W/Y mutants. NB indicates that no significant binding (indicated by lack of any obvious HS
heme iron development) was detected for the indicated mutants. A limit of2% HS heme iron accumulation is given in these cases. This was also the case for the R245L
OleTJE mutant, where no significant optical binding could be detected for any fatty acid tested.
OleTJE
variant
Fatty acid Kd (HS)
C20:0 C18:0 C16:0 C14:0 C12:0 C10:0
M (%)
WT 4.43 0.19 (95) 4.09 0.16 (70) 1.73 0.08 (25) 1.45 0.05 (45) 11.7 0.43 (40) 47.1 2.1 (35)
H85Q 5.27 0.05 (25) 5.92 0.08 (10) 5.36 0.18 (10) 10.5 0.1 (10) 37.3 2.5 (10) NB (2%)
F79A 3.4 0.3 (10) 8.7 0.5 (10) 22.6 1.9 (10) 39.1 2.5 (10) 55.0 4.8 (10) 465 11 (10)
F79W 4.41 0.27 (20) 4.52 0.20 (15) 12.7 0.7 (10) 24.1 0.9 (15) 106 9 (10) NB (2%)
F79Y 4.25 0.21 (10) 8.91 0.33 (10) 18.2 0.7 (10) 30.7 1.0 (20) 196 5 (25) NB (2%)
R245E NB (2%) NB (2%) NB (2%) NB (2%) NB (2%) 1260 160 (40)
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In the case of the R245L mutant, addition of the solvents
ethanol, methanol, and DMSO resulted in the development of
up to10%HSheme iron. This phenomenonwas not observed
with the R245Emutant, likely because of theGlu245 carboxylate
occupying the distal ligand position on the heme iron. This
issue prevented any accurate assessment of the role of fatty
acids in perturbing the R245L heme iron spin state equilibrium,
because spectral changes induced by fatty acids dissolved in
these solventswere of similarmagnitude to those induced using
solvents alone. However, addition of 1 mM lauric acid prepared
in aqueous buffer A produced no significant change in the
R245L UV-visible spectrum. Similarly, addition of a saturating
amount of arachidic acid (in ethanol) did not induce any further
R245L HS heme iron development over that caused by solvent
alone. Thus, fatty acid substrate binding modes in this mutant
may be particularly inefficient in displacement of the axial
water ligand in ferric R245L OleTJE.
The R245E OleTJE mutant exhibits unusual behavior in that
there is no apparent shift in Soret maximum from 423 nm or
development of HS heme iron observed in optical titrations
with any of the fatty acids from C20:0 to C12:0. However, titra-
tion with capric acid (C10:0), resulted in 40% HS heme iron
accumulation at apparent saturation (Fig. 5C). These observa-
tions suggest that the longer chain fatty acids donot bindR245E
OleTJE in a mode that enables HS development/displacement
of a Glu245 axial ligand. However, the substantial HS heme
accumulation in R245E OleTJE on binding capric acid suggests
that this short chain substrate can displace the axial ligand,
albeit with a very high Kd (1260  160 M). Coordination of
heme iron by glutamate oxygen was also observed in the P450
BM3 A264E mutant, with arachidonic acid substrate binding
causing nearly complete distal coordination by the Glu264 car-
boxylate (21, 26). However, the situation may be reversed for
theOleTJE R245Emutant, with capric acid partially displacing a
glutamate ligand at high concentrations.
Stopped FlowKinetic Analysis of Fatty AcidOxidation byWT
and Mutant OleTJE P450s—Stopped flow absorption spectros-
copywas used to probe the effects ofmutations toHis85 (H85Q)
and Phe79 (F79A/W/Y) on the kinetics of OleTJE single turn-
over substrate oxidation reactions. WT, H85Q, and F79A/W
variants were incubated with arachidic acid, whereas F79Y
OleTJE was incubated with nearly saturating lauric acid to
achieve the maximal heme iron spin state conversion for this
mutant. The H2O2-dependent oxidation of substrates was
observed by the rapid HS to LS conversion of the OleTJE heme
iron in each case. Reaction progress was monitored at wave-
lengths close to the ferric, LS Soret maximum for WT OleTJE
and the four mutants. Rate constants for the single turnover
reactions (kobs) were determined usingH2O2 concentrations up
to 200 M. Under the conditions used, plots of kobs versus
[H2O2] were hyperbolic for WT OleTJE and for the H85Q and
F79Y variants. The data were fitted using a hyperbolic function
to derive the limiting rate constant (klim) and the apparent Kd
for H2O2. TheWTOleTJE had values of klim 115 8 s1,Kd
107 16 M, compared with 101 16 s1, 749 141 M for
F79Y, and 286  18 s1, 327  29 M for H85Q. The depen-
dence of kobs versus [H2O2] was linear for the F79A and F79W
mutants, with second order rate constants of 0.188  0.004
M1 s1 and 0.107 0.005 M1 s1, respectively. The com-
parable second order rate constants (klim/Kd) for the other pro-
teins are 1.075  0.236 M1 s1 (WT), 0.875  0.133 M1
s1 (H85Q), and 0.838 0.507 M1 s1 (F79Y).
Stopped flow kinetic data for the reactions of WT and
mutant forms of fatty acid-bound OleTJE with H2O2 indicate
that the WT, H85Q, and F79Y enzyme single turnovers are
more efficient than are those of the other two Phe79 mutants.
Although this is consistent with the superior catalytic proper-
ties of theWT andH85Qmutants in product formation (Table
3), the F79AOleTJE is a more productive enzyme for C10–C16
substrates than are F79Y/W, with more similar levels of prod-
uct formation for the F79A/Y/W mutants with C18 and C20
substrates. However, in view of only minor development of HS
heme iron in arachidic acid-bound F79YOleTJE, lauric acidwas
used instead with the F79Y variant to enhance HS formation
and to improve experimental data quality. In this case it appears
that single turnover efficiency (i.e. the apparent second order
rate constant for F79Y OleTJE-dependent substrate oxidation
byH2O2) is at a level similar to that of theWTandH85QOleTJE
enzymes with arachidic acid. Despite this finding, percentage
product formation for lauric acidwith the F79Ymutant ismuch
lower than observed for the WT/H85Q/F79A OleTJE enzymes
with the same substrate and similar to that for the F79AOleTJE
with arachidic acid. These data suggest that other factors (e.g.
the rate constants for substrate association/product dissocia-
tion and/or efficiency of substrate oxidation with different
chain substrates) have a strong influence on overall product
formation.
Characterization of OleTJE WT and Mutant P450 Heme
Coordination by EPR—Continuous wave X-band EPR spectra
were recorded for WT and all mutant forms of OleTJE in their
substrate-free and arachidic acid-bound states to characterize
the heme coordination state and the influence of mutations to
the key residues in the heme distal pocket. As reported previ-
ously, the substrate-free form ofWTOleTJE has a complex EPR
spectrum with at least four LS (S  1/2) ferric species with
rhombic anisotropy; themost prominent of which have g values
of gz  2.49, gy  2.24, and gx  1.89 (2.49/2.24/1/89) and
2.55/2.24/1.85 (Fig. 6) (10). The g values for these species and
those for all othermutants and their substrate-bound forms are
presented inTable 2. These LS species are consistentwith ferric
heme iron coordinated by cysteine thiolate and a distal water
ligand in a large water-filled active site, and with there being a
variety of coordination geometries and hydrogen bonding
interactions/networks with the distal water ligand. There is no
major contribution from a HS (S  5/2) species in the WT
substrate-free form, but a substantial HS component appears
on the addition of arachidic acid toWTOleTJE. This is split into
twomajor species with g values of 7.76/3.84/1.71 and 7.76/3.67/
1.75. As discussed previously, this heterogeneity likely results
from, for example, changes in conformation of the heme and
thiolate ligand geometry, rather than from any axial ligand
switch in the HS, pentacoordinate state (10). The binding of
arachidic acid also results in a dominant LS form with g values
of 2.47/2.25/1.89, suggesting a much more ordered active site
organization in the substrate-bound state.
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For theH85QOleTJEmutant, the substrate-free LS spectrum
is less complex than that for WT OleTJE. There are two major
LS species at 2.59/2.25/1.85 and 2.49/2/25/1.89. The signal for
the former is broad and may encompass two LS species. The
addition of arachidic acid produces a much smaller HS signal
than inWTOleTJE (with features at gz 7.8 and gy 3.75) and
alters the LS spectrum,with twomajor species at 2.50/2.25/1.88
and 2.48/2.25/1.89. The LS heme iron signals for the H85Q
mutant are quite distinct from those forWTOleTJE in both the
substrate-free and arachidic acid-bound forms, indicating that
the H85Qmutation alters the environment of the distal pocket
around the heme iron, e.g. through altering the hydrogen bond-
ing network to the distal water ligand in the LS substrate-free
form (Fig. 6).
In F79A OleTJE the major LS species is at 2.48/2.25/1.89,
similar to that of themain LS species in theWT enzyme.Minor
species are at 2.65/2.25/1.84 and 2.58/2.25/1.86. The F79Y and
F79W mutants have similar spectra to F79A OleTJE, although
the central set of g values is predominant in these mutants
(2.55/2.26/1.87 and 2.54/2.25/1.86, respectively). Binding of
arachidic acid does not produce any significant HS signal in the
F79A/W mutants, although a small HS signal is observed for
substrate-bound F79Y OleTJE (gz  7.79). However, substrate
does cause some perturbations to the Phe79 mutants LS g val-
ues, particularly in the case of the F79A variant (Table 2). Nota-
bly, there is a large axial HS signal at g 5.99 in both the F79W
and F79Y OleTJE mutants that likely relates to HS penta-co-
ordinated, thiol-ligated, ferric heme species in these mutants.
This observation is consistent with some loss of heme in these
variants, andUV-visible studies of thesemutants also revealed a
propensity for cysteine thiolate protonation of their heme iron
to form the P420 state.
The R245E/L mutants result in less complex substrate-free
EPR spectra than inWTOleTJE, with twomajor, similar sets of
g values for both R245E (2.54/2.25/1.87 and 2.49/2.25/1.89) and
R245L (2.54/2.25/1.87 and 2.46/2.25/1.90). The addition of
arachidic acid has little effect on these LS g values but does
produce a small rhombic HS signal (gz 7.70, gy 3.74) in the
R245L mutant that mirrors the data from UV-visible titrations
and results from effects of the solvent (Fig. 6 and Table 2). The
R245E-capric acid complex proved unstable at the high protein
concentration required for EPR analysis, aggregating and pre-
cipitating at50 M.
Products Formed by Novel OleTJE Mutants—Fatty acid sub-
strate conversion reactions were set up using 1 MWT, H85Q,
F79A/W/Y, and R245L/E OleTJE enzymes and using 200 M
fatty acids (capric acid, lauric acid, myristic acid, palmitic acid,
FIGURE 6. EPR spectroscopic properties of WT and mutant forms of
OleTJE. X-band EPR spectra are shown for WT and H85Q OleTJE mutants in
both ligand-free andarachidic acid substrate-bound (C20:0) formsand for the
F79YandR245EOleTJEmutants in their ligand-free forms. TheWTandmutant
forms ofOleTJE have complex LS EPR spectrawith several distinct species (see
Table 2 for sets of g values). HS heme iron accumulation is seen following
addition of arachidic acid to WT OleTJE (g  7.76/3.84/1.71 and 7.76/3.67/
1.75), but only a very small HS signal is seen for the arachidic acid-bound
H85Qmutant (g 7.80/3.75). The asterisks show signals for a proportion of a
HS penta-coordinated, thiol-ligated, ferric heme species in the H85Q, F79Y,
and R245E mutants.
TABLE 2
EPR g values for substrate-free and fatty acid-bound forms of WT andmutant OleTJE proteins
X-band EPR data were collected at 10 K for the substrate-free and arachidic acid-bound forms of OleTJE. The g values for the LS species and for HS species (where evident)
are presented. In the case of fatty acid-bound forms giving weak HS signals, only those component g values that can be accurately identified are shown. ND indicates not
determined in those cases where no significant HS ferric heme iron signal could be identified or where signals were of insufficient intensity to be accurately assigned. For
each of the OleTJE LS forms, two to four different rhombic species are identified in each case. The most prominent of these species is iidentified as the “Major species” in
each case.
OleTJE variant Rhombic HS signals
Rhombic LS signals (gz/gy/gx)
Major species Minor species
WT ND 2.49/2.24/1.89 2.70/2.24/1.83; 2.61/2.24/1.85; 2.55/2.24/1.85
H85Q ND 2.59/2.25/1.85 2.49/2.25/1.89
F79A ND 2.48/2.25/1.89 2.65/2.25/1.84; 2.58/2.25/1.86
F79W ND 2.54/2.25/1.86 2.65/2.25/1.84; 2.47/2.25/1.89
F79Y ND 2.55/2.26/1.87 2.64/2.26/1.83; 2.48/2.26/1.89
R245L ND 2.54/2.25/1.87 2.65/2.25/1.85; 2.46/2.25/1.90
R245E ND 2.49/2.25/1.89 2.66/2.25/1.83; 2.54/2.25/1.87
WTC20:0 7.76/3.84/1.71; 7.76/3.67/1.75 2.47/2.25/1.89 2.52/2.25/1.87
H85QC20:0 7.80/3.75 2.50/2.25/1.88 2.63/2.25/1.84; 2.48/2.25/1.89
F79AC20:0 ND 2.49/2.26/1.89 2.60/2.26/1.84; 2.54/2.26/1.86
F79WC20:0 ND 2.54/2.25/1.86 2.67/2.25/1.83; 2.46/2.25/1.89
F79YC20:0 7.79 2.56/2.26/1.86 2.65/2.26/1.83; 2.49/2.26/1.89
R245LC20:0 7.70, 3.74 2.53/2.25/1.87 2.65/2.25/1.85; 2.46/2.25/1.90
R245EC20:0 ND 2.53/2.25/1.87 2.67/2.25/1.85; 2.47/2.25/1.90
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stearic acid, or arachidic acid), as described under “Experimen-
tal Procedures.”
ForWTOleTJE, activity was highest for shorter chain length
substrates (C10:0 toC14:0), with essentially complete oxidation
of myristic acid observed. These data are consistent with stud-
ies by Liu et al (12). Activity decreased with longer chain
lengths, possibly because of the lower solubility of the sub-
strates and/or the higher affinity of the terminal alkenes/hy-
droxylated products formed for the OleTJE active site (15). For
all the fatty acids tested with WT OleTJE (C10:0 to C20:0), the
major reaction was decarboxylation of the fatty acids to form
terminal alkenes. For most substrates, 3-hydroxy fatty acid
productsweremore prevalent than 2-hydroxy fatty acids.How-
ever, the reverse was the case for stearic acid (C18:0). When
arachidic acid was used as a substrate, only 1-nonadecene was
detected, with negligible amounts of 2-/3-hydroxy arachidic
acid produced (Fig. 7A and Table 3).
OleTJE His85 was postulated as a proton donor to iron-oxo
species in the WT OleTJE reaction (10). The P450 BS and SP
enzymes have a glutamine at this position, and catalyze pre-
dominantly (BS) or exclusively (SP) fatty acid hydroxylation.
TheH85Qmutant was found to generate a product profile very
similar to that for the wild type OleTJE for all substrates tested
(Fig. 7B and Table 3). The n 1 terminal alkenes are again the
dominant products in all cases, with 3-hydroxy fatty acids
formed to greater extents than 2-hydroxy fatty acids for sub-
strates from C10:0-C16:0. As with WT OleTJE, the 2-hydroxy
stearic acid product is formed to higher levels than 3-hydroxy
stearic acid, and 1-nonadecene is the only significant product
from arachidic acid with H85Q OleTJE.
The F79A OleTJE mutant exhibited decreased activity com-
pared with theWT andH85Q enzymes for all fatty acids tested.
F79A OleTJE mutant activity was highest with lauric acid,
with 80% product conversion (compared with 94%/96% for
WT/H85Q OleTJE), but overall product formation was much
lower with myristic acid (42% for F79A compared with 100%
with WT/H85Q). The F79A OleTJE mutant produced 3-hy-
droxy fatty acids in excess over 2-hydroxy fatty acids for all
substrate chain lengths from C10-C18. For arachidic acid, the
only product formed was 1-nonadecene, albeit with only 5%
conversion (compared with 14%/11% for WT/H85Q OleTJE)
(Table 3).
The F79W/Y mutants were generated to analyze effects of
potentially more conservative mutations to Phe79. However it
was found that, with one exception, both the F79W/Y OleTJE
mutants had much lower activity than F79A OleTJE. The
only outlier was the F79Y mutant with stearic acid substrate,
where overall product formation was 27% compared with
FIGURE 7. Products of fatty acid turnover fromWT andmutant OleTJE enzymes. The bar charts show yields of different alkenes (red), 2-hydroxy fatty acids
(green), and3-hydroxy fatty acids (blue) resulting fromcatalytic turnover byWTandmutant formsofOleTJE, as describedunder “Experimental Procedures.” The
data shown are averages from two sets of experiments, with values varying by 10% in all cases. A shows proportions of the different products formed in
turnover of C10:0, C12:0, C14:0, C16:0, C18:0, and C20:0 substrates by WT OleTJE. B shows the products formed by the R245L OleTJE mutant with the same
substrates, illustrating a switch from fatty acid hydroxylation toward fatty acid decarboxylation (terminal alkene formation) at longer substrate chain lengths.
C showsproducts formed fromtheC14:0 substrate (myristic acid) byWTandallOleTJEmutants.D showsproducts formed fromtheC18:0 substrate (stearic acid)
by WT and all OleTJE mutants.
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20% for F79A OleTJE, because of a higher amount of 1-hep-
tadecene produced by the F79Y mutant. Although amounts
of alkene products from the F79A/W/Y mutants are broadly
comparable for the C18:0 and C20:0 substrates, alkenes are
formed in much lower amounts in the F79W/Y mutants
compared with the F79A OleTJE for the C10:0-C16:0 sub-
strates (Table 3).
Crystallographic data indicated that OleTJE Arg245 plays a
key role in catalysis by coordinating the carboxylate group of
the fatty acid substrate (10). The R245L and R245E OleTJE
mutants were generated and purified to investigate effects of
side chain charge removal and reversal. The R245L/E OleTJE
mutants generally have much lower levels of activity than WT
OleTJE and the two most productive mutants (H85Q and
F79A). However, the R245L/E mutants convert 7.1%/16% ste-
aric acid to 1-heptadecene, with no detectable hydroxylated
products. Almost no decarboxylated product (1-nonadecene)
was observed for these mutants with arachidic acid, and alkene
production was in the range from 0 to 0.6% for the R245L/E
mutants and C10:0-C16:0 substrates (Table 3). The unusual
“switch” from mainly substrate hydroxylase activity at shorter
chain lengths toward decarboxylase activity for stearic acid is
shown in Fig. 7C, and Fig. 7D shows the product profiles from
WT and all OleTJE mutant enzymes with stearic acid (C18:0)
substrate. Alkenes are the major products formed by WT and
all OleTJE mutants with this substrate.
Structural Properties of OleTJE Mutant Enzymes—Crystalli-
zation trials were undertaken for all OleTJE mutant enzymes.
Crystals were obtained for both the H85Q and F79A mutant
P450s in complex with arachidic acid substrate, as well as
for the WT OleTJE in conditions containing formate. In the
latter case, this produced a complex in which formate co-
ordinates the WT OleTJE heme iron in the distal position.
Structures for these mutant enzymes were determined to
1.44 Å (WT/formate), 1.80 Å (H85Q/arachidic acid) and
1.95 Å (F79A/arachidic acid) (Table 4). Attempts to crystal-
lize other mutants were not successful, largely because of
the propensity of other OleTJE mutants to aggregate at high
concentrations.
Few structural changes occur in theOleTJE structure because
of the mutations. Arachidic acid substrate is bound similarly in
both the H85Q and F79A mutants as was previously reported
for the WT OleTJE (10). However, in the WT arachidic acid-
bound structure, a sixth ligand water molecule could not be
distinguished, likely because of the HS state of the WT OleTJE
substrate-ligand complex. In contrast, for both OleTJE H85Q/
F79Amutant structures, a sixth ligandwatermolecule is clearly
visible. A similar situation is observed for the higher resolution
structure of the WT OleTJE-formic acid complex, which
remains LS in solution (Fig. 8). UV-visible substrate binding
data for the H85Q/F79A mutants indicate much smaller HS
shifts than observed for WT OleTJE, consistent with retention
of the aqua-ligated LS state in the major fraction of the mutant
P450s in the crystal structures.
The lack of any large scale structural changes in the H85Q/
F79A OleTJE mutants suggests that that differences in product
profiles for the WT and various OleTJE mutants are linked to
subtle changes in the active site, possibly related to mobility of
active site residues and/or substrates. Minor changes in the
positioning and dynamic behavior of the  and  substrate
hydrogensmight have substantial effects on the product pro-
file but are unlikely to be distinguished using medium reso-
lution crystallography.
TABLE 3
Conversion of fatty acid substrates into alkene and hydroxylated fatty acid products by WT andmutant OleTJE enzymes
The WT, H85Q, R245E/L, and F79A/W/Y OleTJE enzymes were used to catalyze H2O2-dependent decarboxylation/hydroxylation of saturated fatty acid substrates
(C10:0-C20:0) as described under “Experimental Procedures.” The percentage conversions of each fatty acid substrate into their respective (i) n-1 terminal alkene, (ii) 2-OH
fatty acid, and (iii) 3-OH fatty acid products are shown for each OleTJE variant. The percentage of the various products formed in each reaction is given to the nearest 1%
where these products form 10% or more of the total and to the nearest 0.1% where products form less than 10% of the overall yield. The total product formation for
each OleTJE variant/substrate combination is presented in the same way. The data presented are average values from two sets of experiments differing by less than
10% in all cases.
Substrate Products
OleTJE variant and % products formed
WT H85Q F79A F79W F79Y R254L R245E
C10:0 1-Nonene 51 65 37 1.5 0.3 0.1 0.2
2-OH capric acid 5.2 8 1.4 2.1 0 9.3 0
3-OH capric acid 31 25 15 2.1 0 0 0
Total conversion 87 98 53 5.7 0.3 9.4 0.2
C12:0 1-Undecene 80 79 64 1.3 1.3 0 0
2-OH lauric acid 5.2 7.8 7.4 3.6 3.4 2.7 2.6
3-OH lauric acid 9.0 9.2 8.5 1.6 1.4 1.1 1.1
Total conversion 94 96 80 6.5 6.1 3.8 3.7
C14:0 1-Tridecene 72 81 22 0 0 0 0
2-OH myristic acid 3.3 3.1 1.4 1.0 1.2 0.1 1.1
3-OH myristic acid 25 16 19 2.0 3.1 0 0
Total conversion 100 100 42 3.0 4.3 0.1 1.1
C16:0 1-Pentadecene 27 22 9.3 1.2 0.8 0.5 0.6
2-OH palmitic acid 3.6 3.2 2 2 1.6 1.2 1.2
3-OH palmitic acid 12 13 5.1 2.3 1.7 1.5 1.5
Total conversion 43 38 16 5.5 4.1 3.2 3.3
C18:0 1-Heptadecene 40 36 12 11 23 7.1 16
2-OH stearic acid 7 1.4 2.3 0 2.7 0 0
3-OH stearic acid 0.4 0.1 5.9 0.9 0.7 0 0
Total conversion 47 38 20 12 27 7.1 16
C20:0 1-Nonadecene 14 11 5 3.4 2.5 0 0.1
2-OH arachidic acid 0 0 0 0 0 0 0
3-OH arachidic acid 0 0 0 0 0 0 0
Total conversion 14 11 5 3.4 2.5 0 0.1
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Discussion
The peroxygenase enzyme P450 BS (CYP152A1) was dis-
covered in the late 1990s byMatsunaga et al. (27) and shown to
catalyze the H2O2-dependent 1-() and 2-() hydroxylation of
myristic acid, with 2-hydroxy myristic acid being the main
product. Its counterpart P450 SP (CYP152B1) was also iden-
tified by Matsunaga et al. and shown to catalyze the -hydrox-
ylation of lipids, producing 2-hydroxy myristic acid from the
C14:0 substrate, as well as catalyzing 2-hydroxylation of longer
chain saturated fatty acids and mono-unsaturated fatty acids
(28, 29). However, only after studies by Rude et al. (9) was the
capacity revealed of the related OleTJE enzyme (CYP152L1) to
oxidatively decarboxylate fatty acids to form terminal alkenes.
They also demonstrated that 1-pentadecene was formed not
only by H2O2-dependent oxidative decarboxylation of palmitic
acid in OleTJE but also by P450 BS and related P450s from
Corynebacterium efficiens, Kocuria rhizophila, and Methylo-
bacterium populi (9, 30). OleTJE is the most productive of the
fatty acid peroxygenase P450s characterized to date with
respect to its generation of alkene products over hydroxylated
fatty acids. OleTJE was also shown to be functional in alkene
production when driven by a redox partner system or using a
photocatalytic system to generate H2O2 (11, 14). OleTJE is cur-
rently the most studied of the peroxygenase P450s, and the one
with greatest potential for biotechnological applications in pro-
duction of alkenes for use in biofuel production, for example
(31).
The determination of the crystal structure ofOleTJE revealed
a high level of similarity with P450 BS in overall fold and active
site structure (10). TheOleTJE binding pocket ismore extended
than that of P450 BS, explaining its ability to accommodate
fatty acids as long as arachidic acid (C20:0). The OleTJE struc-
ture highlights structural features common to other P450s
(including the heme binding motif surrounding the conserved
cysteine thiolate), as well as key residues involved in interacting
with the substrate carboxylate. Amino acid alignment ofOleTJE
with other characterized P450 peroxygenases reveals that only
48 amino acids are in conserved positions in each of the seven
P450 enzymes aligned, which vary in length from 415 to 428
amino acids (Fig. 2). The substrate carboxylate coordinating
OleTJE Arg245 and its adjacent Pro246 are conserved in all these
peroxygenases, replacing the acid-alcohol pair (e.g. Asp251/
Thr252 in P450cam) found in most mono-oxygenase P450s and
involved in protonation of ferric-peroxo and ferric-hydroper-
oxo catalytic cycle intermediates (3). These keymutations illus-
trate how these peroxygenases have diverged from mono-oxy-
TABLE 4
Data reduction and final structural refinement statistics for OleTJE WT andmutant crystal structures
The data are presented for WT OleTJE bound to formate and for the arachidic acid-bound forms of the H85Q and F79A OleTJE mutants.
OleTJE WT
(formic acid)
OleTJE H85Q
(C20:0)
OleTJE F79A
(C20:0)
Data collection
Space group P43212 P212121 P212121
Cell dimensions
a, b, and c (Å) 60.170, 60.170, 241.70 48.928, 115.494, 163.247 51.88, 110.120, 164.850
, ,  (°) 90, 90, 90 90, 90, 90 90, 90, 90
Rmerge (%) 0.035 (0.625) 0.051 (0.681) 0.057 (0.842)
I/I 25.8 (2.9) 11.4 (2.6) 8.6 (1.8)
Completeness (%) 99.9 (100.0) 99.7 (99.6) 99.6 (99.8)
Redundancy 12.8 (6.5) 6.1 (5.2) 6.5 (6.6)
Refinement
Resolution (Å) 48.21–1.44 (1.47–1.44) 25.50–1.80 (1.83–1.80) 55.06–1.95 (2.00–1.95)
No. reflections 77,736 (5628) 81,942 (5951) 66,360 (4861)
Rwork/Rfree 13.46/17.27 (21.4/28.0) 18.27/21.99 (25.7/29.3) 15.72/20.12 (27.1/33.1)
No. non-hydrogen atoms 3798 7482 7704
Mean B factor (A2) 19.79 27.35 29.706
R.m.s. deviations
Bond lengths (Å) 0.020 0.019 0.013
Bond angles (°) 2.020 1.875 1.270
PDB numbers 5M0N 5M0O 5M0P
FIGURE 8. Active site structures for WT and mutant OleTJE proteins. The three panels show active site details from the crystal structures of WT OleTJE in
complex with formic acid (left panel) and for the F79A (middle panel) and H85Q (right panel) OleTJE mutants bound to arachidic acid. Selected residues in the
active site are shown as atom colored sticks (green carbons), whereas the heme group and associated ligands are shown with purple and cyan carbons,
respectively. Positions ofmutations are labeled in red. Electron density is shown as a bluemesh contoured at 2 for theWTOleTJE-formic acid complex, and at
1.5  for the twomutant structures. Three water molecules are clearly defined in the active site of these three structures (oxygens shown as red spheres), one
of which acts as the sixth ligand to the heme iron.
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genase P450s, exchanging a dipeptide involved in iron-oxo
species protonation for one selected for binding the substrate
carboxylate. The R245E/L mutants are severely catalytically
compromised, consistent with a crucial role of Arg245 in orien-
tating fatty acid carboxylate into a position compatible with
efficient decarboxylation/hydroxylation of the substrate. How-
ever, these mutants do form small amounts of products (Table
3). The R245L/Emutants producedmost alkene from theC18:0
substrate stearic acid but negligible amounts from the C20:0
substrate arachidic acid, potentially because of tighter product
binding for the longer chain substrate.With one exception, the
R245L/E mutants do not exhibit any significant substrate-in-
duced HS ferric heme iron development. Only in the case of
R245Ewith theC10:0 substrate capric acid is there any substan-
tial HS accumulation (40%), albeit achieved at high substrate
concentration (Kd  1260  160 M) (Table 1). The HS con-
version suggests that capric acid does displace Glu245 from a
distal position on the heme iron, although only a small propor-
tion of the substrate is converted to 1-nonene (0.2%), and no
significant formation of hydroxylated forms of capric acid was
observed (Fig. 5C and Table 3).
The H85Q mutant was generated to explore the role of the
OleTJE His85 residue, which is replaced by a glutamine in the
well characterized P450 BS, P450 SP and Clostridium aceto-
butylicum P450 CLA (CYP152A2) enzymes, all of which cata-
lyze predominantly or exclusively fatty acid hydroxylation (33)
(Fig. 2). The OleTJE H85Q mutant gives a very similar product
profile toWTOleTJE with each substrate tested. However, UV-
visible binding studies demonstrate that substrate-induced
H85Q HS heme accumulation is much lower than in the WT
OleTJE in all cases (Tables 1 and 3). EPR studies confirmsmuch
lower accumulation of HS heme iron in arachidic acid-bound
H85Q OleTJE compared with the WT enzyme (Fig. 6). How-
ever, heme spectral shifts are sufficient to determine Kd values
for all substrates with H85Q OleTJE, showing that affinity is
similar to WT OleTJE for longer chain substrates but signifi-
cantly weaker for myristic acid and lauric acid substrates, with
negligible heme spin state change observed on titration of
H85Q OleTJE with capric acid (Table 1). The substantially
diminished (or completely absent) extents of substrate-depen-
dent HS shift in theH85Qmutant are consistent with the prop-
erties of the SP, BS, andCLAperoxygenases (18–20, 33). The
similarity in product profiles between WT and H85Q OleTJE
suggests thatHis85 is not crucial for proton transfer to transient
heme iron-oxo species to facilitate C–C bond scission and alk-
ene production or that alternative pathway(s) exist in theH85Q
mutant. A similar conclusion regarding the non-essentiality of
a histidine in this position was also reached by Amaya et al. (30)
in their studies of theM. populiOleTJE ortholog (CYP-MP), in
which amethionine is located in the relevant position, although
the CYP-MP enzyme is a less efficient decarboxylase than
OleTJE.
OleTJE structural data showed that the His85 imidazole moi-
ety is “sandwiched” between Phe79 and the heme edge (10). The
F79A/Y/W mutants were produced and characterized to
explore the effects of both removing the aromatic side chain
and extending its size and chemical character. All these
mutants showed reduced total activity compared withWT and
H85QOleTJE, with F79AOleTJE being themost active, forming
between 36 and 43% of the product amount fromWTOleTJE in
the same unit time for the C14:0-C20:0 substrates but increas-
ing to 61 and 85% of the amount for the shorter chain capric
acid and lauric acid substrates. The alkenes are themajor prod-
ucts with F79A OleTJE and all substrates, with the 3-hydroxy-
lated fatty acid formed in excess over 2-hydroxyated fatty acids
for the C10-C18 substrates. For the C20:0 arachidic acid, only
1-nonadecene was formed to a detectable level at 5% of the
starting material (Table 3).
Despite the more “conservative” nature of the F79W and
(particularly) the F79Y mutations, the activities of these vari-
ants weremuch lower than observed for F79AOleTJE withC10:
0-C16:0 substrates. Within this group of substrates, hydroxy-
lated fatty acids are formed in excess over alkenes in all cases
except for the F79Ymutant with capric acid (where 1-nonene is
the only product observed at 0.3% of the starting material), and
total product formation does not exceed 6.5% for the F79Y/W
mutants. However, with the C18:0 substrate stearic acid, the
major product is 1-heptadecene (23%/11% products, respec-
tively), and 1-nonadecene is the only product from arachidic
acid (2.5%/3.4% products, respectively).
As is also the case for the H85Q mutant, each of the F79A/
Y/W mutants give less substantial HS heme conversions than
seen in WT OleTJE (Table 1). All Phe79 mutants also show a
similar pattern of decreasing affinity as fatty acid chain length
decreases, with capric acid not inducing any significant heme
spin state change in the F79Y/W OleTJE mutants.
Many bacterial P450s exploit a substrate binding-dependent
LS to HS heme shift to regulate catalytic activity through devel-
opment of a more positive potential in the substrate-bound
formof the heme iron. For example, arachidonic acid binding to
P450 BM3 causes an 140-mV increase in ferric heme iron
reduction potential, facilitating electron transfer from the
linked cytochrome P450 reductase domain to drive catalysis
(34). However, OleTJE shows negligible change in the redox
potential of the hemeFeIII/FeII couple on arachidic acid binding
(105 mV and 103 mV versus normal hydrogen electrode,
respectively,forsubstrate-freeandsubstrate-boundforms),con-
sistent with its dependence on H2O2 for generating reactive
iron-oxo species (10). The relatively positive potential inOleTJE
is likely related in part to the structural arrangement around the
proximal cysteinate ligand. Here, it is notable that a phenylala-
nine residue (typically seven amino acids before the cysteinate)
heavily conserved in mono-oxygenase P450s is absent in all of
the peroxygenases aligned in Fig. 2. Mutations to the relevant
Phe393 residue in P450 BM3 cause substantial changes in heme
iron potential (35, 36). Recent studies showed that OleTJE turn-
over can be driven by heterologous redox partner systems, and
this is likely facilitated by the large driving force (	210mV) for
electron transfer from NAD(P)H through redox partner pro-
teins and onto the substrate-bound OleTJE heme iron (11, 12).
In conclusion,we provide a detailed study of the properties of
WT OleTJE and of important active site mutants of this alkene
producing P450. We show that glutamine substitutes effec-
tively for histidine in the OleTJE H85Qmutant, which has very
similar product profiles to WT OleTJE. The major difference
lies in themuch weaker ability of fatty acid substrates to induce
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HS heme iron formation in the H85Qmutant (Fig. 5B), a prop-
erty consistent with those of the P450 SP and P450 BS per-
oxygenases, both of which have a glutamine in the same posi-
tion (20, 38). The data appear to rule out a key role for His85 in
proton donation to reactive iron-oxo species in OleTJE, and
suggest that the system is robust and that alternative protona-
tion pathway(s) may exist. Mutations to OleTJE Phe79 also
diminish substrate-dependent heme HS conversion and
weaken affinity for shorter chain (C10:0-C16:0) fatty acid sub-
strates. This translates into much lower product formation for
the F79Y/W mutants from these substrates, although F79A
OleTJE is less severely affected, with between 36 and 85%overall
product formation compared with that of WT OleTJE for C10:
0-C20:0 substrates (Table 3). These data indicate that the more
“conservative” F79Y/Wmutations are actually more disruptive
to active site structure and catalytic efficiency than is the F79A
mutation, a conclusion consistent with the greater propensity
of the F79Y/Wmutants to aggregate/precipitate and their fail-
ure to crystallize. These properties are sharedwith the R245L/E
variants, in which the substrate carboxylate tethering Arg245 is
mutated. Each of the F79Y/W and R245E/L mutations show
some heme depletion, with R245E OleTJE being the worst
affected (Fig. 4B). The red-shifted (423 nm) Soret band of the
oxidized R245EOleTJE protein suggests that the glutamatemay
coordinate the heme iron in the ferric state. The R245L/E
mutants retain low activity, with stearic acid (C18:0) being the
best substrate and forming the greatest amounts of alkene
product for both mutants (Table 3). Crystal structure data for
the H85Q and F79A mutants reveal only minor alterations to
OleTJE active site structure, suggesting that quite subtle
changes in the positions of active site amino acids, water mol-
ecule(s), and the substrate carboxylate region may be sufficient
to trigger catalysis when H2O2 binds to initiate compound 0
formation. Makris’s group have revealed how this could lead to
substrate hydroxylation by the radical rebound mechanism,
involving hydrogen atom abstraction from the substrate by
compound I and subsequent “rebound” of the hydroxyl group
to the substrate radical (5). However, through their identifica-
tion and characterization of the transient ferryl-hydroxo com-
pound II, a novel mechanism for substrate decarboxylation was
proposed. In this model, compound II abstracts a further elec-
tron from the substrate radical to form a diradical or carboca-
tion intermediate (Fig. 1), which decarboxylates to form CO2
and the n  1 terminal alkene, with protonation of the ferric-
hydroxo species restoring the water-coordinated resting form
of the heme iron (15, 39). Further protein engineering studies
on OleTJE are now clearly needed to improve its stability and
catalytic performance as an alkene producing enzyme and to
facilitate its biotechnological application.
Experimental Procedures
Expression and Purification of OleTJE and OleTJE Mutants—
The gene encoding OleTJE from Jeotgalicoccus sp. ATCC 8456
was codon-optimized for expression in E. coli and cloned into a
modified pET15b (GenScript, Cherwell, UK), incorporating a
TEV cleavage site with an N-terminal polyhistidine tag. Ratio-
nally designedmutants (H85Q, F79A, F79W, F79Y, R245L, and
R245E) were created by site-directed mutagenesis, using a
QuikChange Lightning kit (Agilent Technologies LDAUKLtd.,
Cheadle, UK). The oligonucleotide primers used were: H85Q
forward, 5
-ttttaccatcaaccgtctg gattgcgcctttaccaaac-3
; H85Q
reverse, 5
-gtttggtaaaggcgcaatccagacggttgatggtaaaa-3
; F79A
forward, 5
-gtatggattgcgcctttaccagccagggtattcacaatacgttt-3
;
F79A reverse, 5
-aaacgtattgtgaataccctggctggtaaaggcgcaatc-
catac-3
; F79W forward, 5
-attgcgcctttaccc cacagggtattca-
caatacgtttcggc-3
; F79W reverse, 5
-gccgaaacgtattgtgaataccct-
gtggggtaaaggcgcatt-3
; F79Y forward, 5
 tgcgcctttaccatacag-
ggtattcacaatacgtttcg-3
; F79Y reverse, 5
-cgaaacgtattgtgaata-
ccctgtatggtaaaggcgca-3
; R245L forward, 5
-gatgaacacgttcctgc-
cgctgattgcgatc-3
; R245L reverse, 5
-gatcgcaatcagcggcag-
gaacgtgttcatc-3
; R245E forward, 5
-ttgatctgatgaacacgttcgagc-
cgctgattgcgatcaatcg-3
 and R245E reverse, 5
-cgattgatcg-
caatcagcggctcgaacgtgttcatcagatcaa-3
. E. coli strain C41 (DE3)
(Lucigen, Middleton, UK) was used as the expression host for
WT OleTJE and all mutants. Cells transformed with the plas-
mids were grown at 37 °C with shaking at 200 rpm in total
volumes of 500 ml of 2YT broth containing 50 g/ml ampicil-
lin. Expression of WT/mutant OleTJE genes was induced
with 100 M isopropyl 1-thio--D-galactopyranoside when an
OD600 of 0.5 was reached. At point of induction, 500M -ami-
nolevulinic acid was added to all mutants, and 4 g/ml hemin
was also added to the R245L and R245E expression cultures to
aid heme incorporation. At this point, the incubation temper-
ature was lowered to 25 °C, and the cells were grown for a fur-
ther 16 h. The cells were harvested by centrifugation at 6000
rpm at 4 °C using a JLA-8.1000 rotor in an Avanti J-26 XP cen-
trifuge. The cells were resuspended in 100mM potassium phos-
phate (pH 8.0), combined, and centrifuged as before. The cell
pellet was then frozen at80 °C until required for purification.
Cells were thawed and resuspended in 200 g/liter extraction
buffer (100 mM potassium phosphate, 1 M NaCl, 10% glycerol,
pH 8.0) along with SigmaFAST protease inhibitor mixture tab-
lets, EDTA-Free (Sigma-Aldrich) using 1 tablet/100 ml, and
100g/ml DNase I (bovine pancreas; Sigma-Aldrich). The cells
were lysed using a cell disruptor (Constant Cell Disruption Sys-
tems, Daventry, UK) at a pressure of 15,000 p.s.i. The homoge-
natewas then centrifuged at 20,000 rpmat 4 °C for 90min using
a JA-25.50 rotor (Beckman-Coulter Ltd., HighWycombe, UK).
The supernatant was removed and incubated overnight at 4 °C
with (10 ml/100 g of cell pellet) Ni-IDA chromatographic
medium (Generon, Maidenhead, UK). The mixture was then
transferred to a column, and the resin bed was washed with 20
column volumes of buffer A (100 mM KPi, 750 mM NaCl, 10%
glycerol, pH 8.0) containing 50 mM imidazole. The resin was
then washed with 2 column volumes of buffer A with 150 mM
imidazole, and the protein was eluted in buffer A with 175 mM
imidazole. For OleTJE samples not destined for protein crystal-
lization, the protein was extensively dialyzed into buffer A to
remove any imidazole and bound fatty acids retained from
expression in E. coli and then concentrated by ultrafiltration in
aVivaspin (30,000molecularweight cutoff; GEHealthcare) and
transferred to buffer B (100 mM KPi, 750 mM NaCl, 20% glyc-
erol, pH 8.0) using a PD 10 desalting column (GE Healthcare).
The protein was then snap frozen in liquid nitrogen and stored
at 80 °C until required. Protein destined for crystallography
was not frozen at this point, and instead TEV protease (500
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units) was added to the eluted protein to remove the His tag,
and the sample was incubated at 4 °C overnight. The S219V
variant of TEV protease was expressed using plasmid pRK793
(Addgene plasmid no. 8827) (37). The protein was then
exchanged into buffer A using a PD10 desalting column and
added to a bed ofNi-IDA resin. Cleaved proteinwas elutedwith
buffer A including 20 mM imidazole. This was then dialyzed
extensively to remove imidazole and bound lipids. The protein
was concentrated using a Vivaspin and then gel-filtered using a
Superdex 200 16/600 (GEHealthcare) column pre-equilibrated
with buffer C (100 mM KPi, 750 mM NaCl, pH 8.0).
UV-visible Spectroscopy of WT and Mutant OleTJE
Hemoproteins—The UV-visible spectra of WT and mutant
forms OleTJE were collected using a Cary 60 UV-visible spec-
trophotometer (Agilent). Spectra were recorded at ambient
temperature for the proteins in buffer A, typically at concentra-
tions of4–6M.The ferrous and FeII-CO forms of the hemo-
proteins were produced under anaerobic conditions using
degassed buffer A. Reduced enzymes were formed by the addi-
tion of a few grains of solid sodium dithionite to ferric enzymes.
The FeII-CO complexes were then formed by slowly bubbling
CO gas into reduced OleTJE proteins until no further spectral
shift was observed.
Fatty Acid Binding Titrations with OleTJEMutants—Binding
of saturated fatty acids (C12:0, C14:0, C16:0, C18:0, and C20:0)
to the OleTJE mutants was performed at 25 °C in buffer A. Sub-
strates were dissolved in 100% ethanol, and additions of 0.5-l
aliquots of substrate stocks (of concentration from 1–100 mM,
according to the particular substrate and its affinity for the
P450s) were made until no further spectral shift was observed.
Spectra (800–300 nm) were recorded using a Cary 60 UV-vis-
ible spectrophotometer. Difference spectra were obtained by
subtracting the ligand-free spectrum of the P450 from the
ligand-boundspectraateachsubstrateconcentration.Theabsor-
bance difference maximum (Apeak) and minimum (Atrough)
were then identified from the individual data sets, and themax-
imal absorbance change (Amax) was calculated by subtracting
Atrough from Apeak in each case, using the same wavelength
pair throughout each individual titration.Amax was then plot-
ted against substrate concentration, and the data were fitted
using either a hyperbolic (Michaelis-Menten or Morrison
equations) (32) or a sigmoidal (Hill) function to determine the
dissociation constants (Kd values) for fatty acid substrate
binding.
Stopped Flow Kinetic Analysis of Substrate Oxidation by
OleTJE WT and Mutant Enzymes—An Applied Photophysics
SX18 MR stopped flow spectrophotometer with a photodiode
array detector (Leatherhead, UK) was used to collect stopped
flow absorption data. For the WT, H85Q, F79A, and F79W
OleTJEmutants, a 2.5molar excess of arachidic acid (C20:0)was
mixed with these P450 samples (giving a final P450 concentra-
tion of 5 M), and the mixture was passed through a 0.2-m
syringe filter (Sartorius UK Ltd., Epsom, UK) to remove excess
lipids from the P450 protein solution. A nearly saturated aque-
ous solution of lauric acid (C12:0, 250 M) was mixed with the
F79Y mutant (again giving a final P450 concentration of 5 M)
and passed through a 0.2-m syringe filter as above. The sub-
strate-bound OleTJE proteins were then mixed with different
concentrations of H2O2 (final concentration post-mixing,
6.25–200 M) in the stopped flow instrument at 25 °C.
Conversion of the fatty acid-bound, HS ferric forms of the
OleTJE enzymes to their LS forms was monitored at 421 nm for
the OleTJE WT and OleTJE H85Q mutant enzymes and at 423
nm for the OleTJE F79A enzyme. The data were fitted using a
single exponential function and using the Pro-Data SX software
suite (Applied Photophysics). The observed reaction rate con-
stants (kobs values) were plotted against the relevant H2O2 con-
centration, and the datawere fitted using a hyperbolic (Michae-
lis-Menten) function (for the WT, F79Y, and H85Q OleTJE
enzymes) or using a linear function in the case of the other
OleTJE mutants.
EPR Analysis of OleTJE Mutants—Continuous wave X-band
EPR spectra for the OleTJE WT and mutant P450s were
obtained at 10 K using a Bruker ELEXSYS E500 EPR spectrom-
eter with an ER 4122SHQ Super High Q cavity. Temperature
was controlled with an ESR900 cryostat (Oxford Instruments,
Abingdon, UK). EPR spectra were collected forWT andOleTJE
mutants at concentrations of 100–200 M for ligand-free,
arachidic acid-bound, and imidazole-bound forms. Arachidic
acid was added to dilute OleTJE protein until the UV-visible
spectrum showed no further optical change toward high spin.
The enzyme was then concentrated to an appropriate concen-
tration (200 M for WT, H85Q, and F79A OleTJE; 150 M for
R245L OleTJE; and 100 M for the F79W, F79Y, and R245E
mutants) (the latter in its substrate-free form), taking into con-
sideration that some of the mutants are prone to precipitation
at high concentrations) using a Vivaspin (30,000 molecular
weight cutoff).
Crystallography of the OleTJE H85Q and OleTJE F79A
Mutants—Crystallization trials for the OleTJE H85Q and
OleTJE F79Amutant enzymeswere carried out with 400 nl (200
nl of protein and 200 nl of precipitant) sitting drops in MRC
96-well plates (Molecular Dimensions, Newmarket, UK).
Molecular Dimensions screens Clear Strategy Screen I, Clear
Strategy Screen II, PACT premier, JCSG-plus, and Morpheus
were used for OleTJE H85Q. Diffracting crystals were taken
from well H10 of JCSG-plus (0.2 M ammonium acetate, 0.1 M
Bis-Tris, 25% (w/v) PEG 3350, pH 5.5). For OleTJE F79A, C3
Shotgun Screen (SG1) and JCSG-plus screens were used. Crys-
tals formed were used to make a seed stock, and further plates
were set up using an optimized screen. Diffracting crystals were
grown in 0.2 M MgCl2, 0.1 M HEPES, 20% PEG 6000 (pH 7.5).
Plates were set up using a Mosquito nanoliter pipetting robot
(TTP Labtech, Melbourn, UK). For OleTJE H85Q, ligand-free
and arachidic acid-bound proteinswere used for crystal trials at
a concentration of 11.5 mg/ml. For the OleTJE F79A mutant,
arachidic acid-bound enzyme was used at a protein concentra-
tion of 13.5 mg/ml. Arachidic acid was bound to the proteins in
the same way as described for the EPR studies.
Fatty Acid Substrate Conversion Reactions with WT and
Mutant OleTJE Enzymes—Fatty acid substrate conversion reac-
tions were set up using 1 M of wild-type, H85Q, F79A, F79W,
F79Y, R245L, and R245E OleTJE enzymes. The proteins were
incubated with 200 M fatty acid (capric acid, lauric acid, myr-
istic acid, palmitic acid, stearic acid, or arachidic acid), and the
reactions were started by the addition of 400MH2O2 in a total
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volume of 500 l of buffer A. The reactions were incubated at
32 °C with shaking for 30 min. Thereafter, reactions were
stopped by acidifying with 20 l of 37% HCl. For the C10:0,
C12:0, and C16:0 reactions, the internal standards 1-undecene,
myristic acid (C14:0), -OH myristic acid, and -OH myristic
acid were added. For the C14:0, C18:0, and C20:0 reactions,
internal standards 1-pentadecene, palmitic acid (C16:0), -OH
palmitic acid, and -OH palmitic acid were added. After com-
pletion of the reactions, the mixtures were extracted with
an equal volume of dichloromethane. The dichloromethane
extract was then dried with anhydrous magnesium sulfate
before the product sample was subjected to GC/MS analysis.
Characterization of Fatty Acid Oxidation Products Using
GC/MS—Analysis of products formed by fatty acid oxidation
usingWT and mutant OleTJE enzymes was done using an Agi-
lent 6977A series GC/MSD installed with an Agilent HP-5MS
UI 30 m 0.250 mm 0.25 M column (helium flow rate, 1.2
ml/min) (Agilent). A 1-l sample was injected via sandwich
injection with 1l ofN,O-bis(trimethylsilyl)trifluoroacetamide
containing 1% trimethylchlorosilane to derivatize fatty acids
and hydroxylated fatty acids. The split ratio was 10:1, and the
inlet was set to a temperature of 280 °C. The oven temperature
was held at 40 °C for 1 min and then ramped at 10 °C/min to
290 °C, where it was held for 1 min. Electronic ionization was
used, scanning ions in the range of 40–550 m/z at a tempera-
ture of 250 °C. For quantitation, external standard calibrations
were generated, and the selected ion monitoring mode was
used to identify appropriate m/z ion fragments for substrate
and product analysis.
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